tiprankstipranks
Lixte Biotechnology Holdings, Inc. (LIXT)
:LIXT
US Market

Lixte Biotechnology Holdings (LIXT) Income Statement

Compare
70 Followers

Lixte Biotechnology Holdings Income Statement

Last quarter (Q4 2024), Lixte Biotechnology Holdings's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q4, Lixte Biotechnology Holdings's net income was $-617.69K. See Lixte Biotechnology Holdings’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Operating Expenses
$ 3.57M$ 5.09M$ 6.31M$ 6.72M$ 3.27M
Depreciation and Amortization
$ 0.00$ 5.09M$ 6.31M$ 6.72M$ 3.27M
EBITDA
$ -3.57M$ 3.21K$ -1.05K$ -7.95K$ 1.56K
Operating Income
$ -3.57M$ -5.09M$ -6.31M$ -6.72M$ -3.27M
Other Income/Expenses
$ -13.18K$ 3.21K$ -1.05K$ -7.95K$ 1.56K
Pretax Income
$ -3.59M$ -5.09M$ -6.31M$ -6.73M$ -3.26M
Net Income
$ -3.59M$ -5.09M$ -6.30M$ -6.74M$ -3.26M
Per Share Metrics
Basic EPS
$ -1.59$ -2.66$ -4.00$ -5.00$ -2.89
Diluted EPS
$ -1.59$ -2.66$ -4.00$ -5.00$ -2.89
Weighted Average Shares Outstanding
2.25M 1.91M 1.58M 1.35M 1.13M
Weighted Average Shares Outstanding (Diluted)
2.25M 1.92M 1.58M 1.35M 1.13M
Currency in USD

Lixte Biotechnology Holdings Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis